Title: HMid-Hospital Medicine – Infectious Diseases: Bloodstream Infections/Endocarditis; Multi-Drug Resistant; Skin/Soft Tissue

Faculty: John K. Crane, M.D., PhD., Blair Weikert, M.D.

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: Bloodstream Infections and Endocarditis.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Analyze the epidemiology and risk factors for bloodstream infections and endocarditis in patients presenting to a primary care practice.
2. Employ the diagnosis and management skills for bloodstream infections and infective endocarditis as per the current IDSA guidelines.
3. Recognize post-infection patient management issues and apply appropriate endocarditis prophylaxis measures as per the AHA guidelines

TOPIC 2: Multi-Drug Resistant Infections.

Upon completion of this session, the participant should be able to: ^{EBM, COMP}

1. Assess to identify and avoid or minimize the urgent and serious threats of drug resistance as identified by the CDC and IDSA.
2. Apply the most effective and appropriate treatment and strategy for each infection.
3. Determine when specialist referral will result in an improved outcome.

TOPIC 3: Skin and Soft Tissue infections.

Management of skin and soft tissue infections continues to be common in primary care.  They can range from uncomplicated which is managed in the outpatient setting to problematic requiring inpatient care, An evidence-based approach to diagnosis and treatment from JAMA dermatology, Clinical Infectious Diseases, CDC guidance published in the MMWR, and NEJM will be reviewed. Upon completion of this session, the participant should be able to: ^{COMP, EBM, GL}

1. Differentiate between skin and soft tissue infections that require antibiotic coverage for anaerobes and those that do not.
2. Accurately diagnose venous stasis dermatitis as a non-infectious entity.
3. Correctly formulate treatment plans for animal and human bites.
4. Identify 2 or more non-infectious diagnoses that resemble “bilateral cellulitis”

Title: HMne-Hospital Medicine - Neurology: Headaches; Stroke; Syncope/Vertigo

Faculty:Gerald W. Smetana, M.D., M.A.C.P,. Kendal Williams, M.D., M.P.H.

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1 Treatment of Primary Headache Syndromes.

Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}

1. Appreciate the role of abortive therapy for migraine, tension-type, and cluster headaches.
2. Recognize the range of options for pharmacologic acute and preventive therapy, as recommended by the AHS 2015 Evidence-Based recommendations for migraine, as well as options for tension-type, and cluster headaches.
3. Develop non-pharmacologic treatment strategies for migraine as per the most recent Cochrane Systematic Review.

TOPIC 2 Update on the Management of Stroke and Transient Ischemic Attack.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Assess common presentations of cerebrovascular insufficiency.
2. Prescribe the initial management of patients with a suspected acute CVA.
3. Apply cutting edge strategies and therapies for the management of hemorrhagic and thrombotic strokes.
4. Distinguish between stroke and TIA and appropriately assess the patient with TIA for early risk of stroke.
5. Formulate an effective post-stroke secondary prevention plan as per the AHA/ASA guidelines.

TOPIC 3: The Evaluation and Management of Syncope and Vertigo.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Appropriately evaluate patients with syncope or vertigo.
2. Formulate a diagnostic evaluation strategy of syncope or vertigo that is based on best practices and the 2017 ACC/AHA/HRS guidelines.
3. Debate the value of the various diagnostic approaches to the workup of syncope.
4. Prescribe an effective therapeutic strategy for the management of both syncope and vertigo per the 2017 ACC/AHA/HRS guidelines.